Gastrointestinal
FDA Approves OTC Nexium for Heartburn
04/01/2014 FDA has approved over-the-counter (OTC) Nexium® 24HR (espmerprazole magnesium) for treatment of frequent heartburn. Nexium is a proton pump inhibitor (PPI) that reduces the amount of acid in the stomach. Nexium was originally developed by AstraZeneca and approved as a prescription medicine to treat gastroesophageal reflux disease (GERD), gastric ulcers, duodenal ulcers, and hypersecretory conditions such as Zollinger-Ellison syndrome. Pfizer acquired rights from AstraZeneca to market non-prescription Nexium. "Switching medicines, whenever appropriate, from prescription to nonprescription status improves access, empowers consumers to care for their own health and is an important strategy for Pfizer," said Paul Sturman, President of Pfizer Consumer Healthcare. [1] FDA Reference ID: 3460353. Nexium® Medication Guide (2014). [2] Pfizer Statement on U.S. FDA Approval of Over-the-Counter Nexium® 24HR |
If you have experienced adverse events or side effects from a gastrointestinal medication find help here.
|